Evidence map›Paper›PMID 42907501›Full record

ArticleNature2026

Structural basis for protocadherin-1 recognition by New World hantaviruses.

Leandro Battini, Megan M Slough, Ramandeep Kaur, Luqiang Guo, Catalina Florez, Alexandra Serris, Annalisa Meola, Gorka Lasso, Nicole D Tischler, Raymond Alvarez and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Leandro Battini *Structural Biology of Infectious Diseases G5+ Unit, Institut Pasteur, Université Paris Cité, Paris, France.ORCID http://orcid.org/0009-0008-9937-9212
Megan M Slough *Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Ramandeep Kaur *Department of Microbiology and Immunology, Center for Applied Immunology and Pathological Processes, Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA.ORCID http://orcid.org/0000-0002-8034-7199
Luqiang GuoDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
Catalina FlorezU.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.
Alexandra SerrisInstitut Pasteur, Université Paris Cité, CNRS UMR 3569, Unité de Virologie Structurale, Paris, France.
Annalisa MeolaStructural Biology of Infectious Diseases G5+ Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Gorka LassoDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Nicole D TischlerLaboratorio de Virología Molecular, Centro Ciencia & Vida, Fundación Ciencia & Vida, Santiago, Chile.ORCID http://orcid.org/0000-0002-4578-4780
Raymond AlvarezIchor Biologics, New York, NY, USA.
Upendra P LambeDepartment of Microbiology and Immunology, Center for Applied Immunology and Pathological Processes, Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA.
Lohit KheraDepartment of Microbiology and Immunology, Center for Applied Immunology and Pathological Processes, Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA.
Jian WangDepartment of Microbiology and Immunology, Center for Applied Immunology and Pathological Processes, Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA.
Rona S ScottDepartment of Microbiology and Immunology, Center for Applied Immunology and Pathological Processes, Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA.
Jose L GarridoIchor Biologics, New York, NY, USA.
Maria I BarriaIchor Biologics, New York, NY, USA.
Nicole M JosleynU.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.
Félix A ReyInstitut Pasteur, Université Paris Cité, CNRS UMR 3569, Unité de Virologie Structurale, Paris, France.
Andrew S HerbertU.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.ORCID http://orcid.org/0009-0001-5256-7733
Jason S McLellanDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.ORCID http://orcid.org/0000-0003-3991-542X
Rohit K JangraDepartment of Microbiology and Immunology, Center for Applied Immunology and Pathological Processes, Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA. rohit.jangra@lsuhs.edu.ORCID http://orcid.org/0000-0002-3119-0869
Kartik ChandranDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA. kartik.chandran@einsteinmed.edu.ORCID http://orcid.org/0000-0003-0232-7077
Pablo Guardado-CalvoStructural Biology of Infectious Diseases G5+ Unit, Institut Pasteur, Université Paris Cité, Paris, France. guardado@pasteur.fr.ORCID http://orcid.org/0000-0001-7292-5270

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hantaviruses are rodent-borne pathogens that cause severe human disease for which no approved therapeutics are available. New World hantaviruses, including Andes virus (ANDV), use the cell-surface receptor protocadherin-1 (PCDH1) to enter host cells

Identifiers

PMID42907501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.